CorNeat Vision is a pioneering medical device company. Its non-degradable tissue-integrating material technology, CorNeat EverMatrix™, has the potential for improved outcomes by minimizing the body’s natural immune system response to foreign bodies. The company’s emerging product portfolio also includes a synthetic cornea, the CorNeat KPro; a glaucoma drainage device, the CorNeat eShunt; a periodontal regeneration […]
CILIATECH develops the first implant in the industry to reduce IOP without penetrating the anterior chamber nor creating subconjunctival filtration. CILIATECH’S implant (invented by Dr SOURDILLE) is a Cilioscleral Interpositioning Device (CID) made of hydrophilic hydrogel used in IOLs. This platelike device (6*4*0.4 mm) is designed to separate the sclera and the ciliary muscle that […]
Founded in 2016, NovaSight has experienced rapid growth by delivering end-to-end eye-tracking-based vision care solutions. The company focuses on three major verticals: vision treatment, vision diagnostics and prevention and monitoring of visual health conditions. The CureSight™ is an FDA cleared and CE marked eye tracking-based system for treatment of lazy eye designed to replace the traditional […]
m-lab GmbH is a spin-off from the University of Mainz, Germany. We are developing and commercializing innovative point-of-care n(POC) devices and personalized treatment approaches in Ophthalmology. The initial product, a Glaucoma diagnostic platform, will provide early detection of Glaucoma, the most prevalent cause of blindness in the world today, by means of an affordable, easy-to- […]
Glaucoma is one of the most common causes of permanent blindness. Even if patients regulate their intraocular pressure with today’s gold standard treatment techniques, the disease progresses for most of the patients and causes the permanent blindness and this is irreversible. Recent studies show that glaucoma is actually not only an eye disease but also […]
Orasis Pharmaceuticals is an emerging ophthalmic pharmaceutical company developing an optimized formulation of a presbyopia correcting prescription eye drop, CSF-1. From the beginning, having the patient in mind, we realized that in order to have a successful alternative to reading glasses, we needed an optimal balance of efficacy safety and comfort. Identifying the minimal effective […]
W.L. Gore & Associates is a material science company and a leading developer of successful medical devices with applications in cardiovascular and general surgery. Through our unique material technologies, we provide differentiated solutions to clinically critical unmet needs. Tasked with identifying new growth areas, we are investigating the value of our materials and medical device […]
Kejako developped a finite element model of the human eye and demonstrated the human accomodation processes as well as it loss and confirmed the explaination of presbyopia in silico. Thereafter Kejako performed a feasibility experimentation on hundreds of pig eyes and confirmed the ability of the technology to restore circa 1,5 diopters of accomodation thanks […]
TearLab, founded in 2009, was built upon the recognition of the importance of corneal health to eye care practices. We introduced tear osmolarity testing to eye care with our flagship device, the TearLab Osmolarity System, which has been used to perform over 24 million tests worldwide. In 2022, we announced a corporate name change to […]
The only quantification AI tool which detects all types of pathologies which define diagnoses and its severity. It also considers size and location in relation to anatomical structures of the posterior eye. Quantification does allow for perfect tracking of progression and or regression of the disease which is only possible to detection of all and […]
